INTRODUCTION
This paper presents a case for the need to improve knowledge transfer (more broadly knowledge management) as part the technology transfer stage in the pharmaceutical product lifecycle. The importance of effective knowledge transfer to enabling successful technology transfer is established and the current effectiveness is characterized using multiple inputs which are assessed, reported, and discussed.
While knowledge management (KM) approaches have been widely applied in other sectors, the international biopharmaceutical sector has struggled with meaningful and sustained application...
This content is only available to IVT members.
Get help maintaining your knowledge in Protocols & SOPs. Read More!
If you are already a member and you do not have access to this article, upgrade your membership.
Need help? Read our FAQs.
This product has been added to your shopping cart. You can
continue shopping or proceed to
checkout.